COVID-19 recovery: potential treatments for post-intensive care syndrome.
作者信息
Bangash Mansoor N, Owen Andrew, Alderman Joseph E, Chotalia Minesh, Patel Jaimin M, Parekh Dhruv
机构信息
Intensive Care Unit, Queen Elizabeth Hospital, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham B15 2GW, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
Intensive Care Unit, Queen Elizabeth Hospital, University Hospitals Birmingham National Health Service Foundation Trust, Birmingham B15 2GW, UK; Birmingham Acute Care Research Group, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, UK.
出版信息
Lancet Respir Med. 2020 Nov;8(11):1071-1073. doi: 10.1016/S2213-2600(20)30457-4. Epub 2020 Oct 12.
Abstract
摘要
相似文献
1
COVID-19 recovery: potential treatments for post-intensive care syndrome.新冠病毒病康复：重症监护后综合征的潜在治疗方法
Lancet Respir Med. 2020 Nov;8(11):1071-1073. doi: 10.1016/S2213-2600(20)30457-4. Epub 2020 Oct 12.
2
Noteworthy Electrocardiographic Changes Following Pharmacologic Treatment of COVID-19.新型冠状病毒肺炎药物治疗后的显著心电图变化
Am J Crit Care. 2020 Sep 1;29(5):407-408. doi: 10.4037/ajcc2020779.
3
High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19.高呼吸驱动和过度呼吸努力预示着新冠肺炎危重症患者呼吸衰竭的复发。
Am J Respir Crit Care Med. 2020 Oct 15;202(8):1173-1178. doi: 10.1164/rccm.202005-1582LE.
4
Tocilizumab plus glucocorticoids in severe and critically COVID-19 patients. A single center experience.托珠单抗联合糖皮质激素治疗重症和危重症 COVID-19 患者：单中心经验
Med Clin (Barc). 2020 Nov 13;155(9):410-411. doi: 10.1016/j.medcli.2020.07.001. Epub 2020 Jul 9.
5
Covid-19 in China: ten critical issues for intensive care medicine.中国的新冠疫情：重症医学的十个关键问题
Crit Care. 2020 Mar 31;24(1):124. doi: 10.1186/s13054-020-02848-z.
6
Physiological Changes During Prone Positioning in COVID-19 Acute Respiratory Distress Syndrome.新型冠状病毒肺炎急性呼吸窘迫综合征俯卧位通气期间的生理变化
Ann Acad Med Singap. 2020 Jul;49(7):509-513.
7
The pathogenesis and treatment of the `Cytokine Storm' in COVID-19.新型冠状病毒病中“细胞因子风暴”的发病机制与治疗。
J Infect. 2020 Jun;80(6):607-613. doi: 10.1016/j.jinf.2020.03.037. Epub 2020 Apr 10.
8
COVID-19: opening a new paradigm in thromboprophylaxis for critically ill patients?新冠病毒肺炎：为重症患者的血栓预防开启新范式？
Crit Care. 2020 Jun 11;24(1):332. doi: 10.1186/s13054-020-03052-9.
9
Anticipating and managing coagulopathy and thrombotic manifestations of severe COVID-19.预测和处理重症新型冠状病毒肺炎的凝血功能障碍及血栓形成表现
CMAJ. 2020 Oct 5;192(40):E1156-E1161. doi: 10.1503/cmaj.201240. Epub 2020 Aug 16.
10
Hybrid tracheotomy. A valid alternative for obese critical patients COVID-19.杂交气管切开术。肥胖COVID-19重症患者的有效替代方案。
Rev Esp Anestesiol Reanim (Engl Ed). 2020 Oct;67(8):483-484. doi: 10.1016/j.redar.2020.06.013. Epub 2020 Jul 11.
引用本文的文献
1
Using machine learning involving diagnoses and medications as a risk prediction tool for post-acute sequelae of COVID-19 (PASC) in primary care.在初级医疗保健中，将涉及诊断和药物治疗的机器学习作为新冠后急性后遗症（PASC）的风险预测工具。
BMC Med. 2025 Apr 30;23(1):251. doi: 10.1186/s12916-025-04050-w.
2
Post-intensive care syndrome and pulmonary fibrosis in patients surviving ARDS-pneumonia of COVID-19 and non-COVID-19 etiologies.COVID-19 和非 COVID-19 病因导致的 ARDS-肺炎存活患者的重症监护后综合征和肺纤维化。
Sci Rep. 2023 Apr 21;13(1):6554. doi: 10.1038/s41598-023-32699-x.
3
Nutritional and metabolic management of COVID-19 intensive care patients.新型冠状病毒肺炎重症监护患者的营养与代谢管理
J Intensive Med. 2021 Feb 5;1(1):31-34. doi: 10.1016/j.jointm.2021.01.004. eCollection 2021 Jul.
4
Post-acute sequelae of COVID-19 among hospitalized patients in Estonia: Nationwide matched cohort study.COVID-19 后在爱沙尼亚住院患者中的后遗症：全国匹配队列研究。
PLoS One. 2022 Nov 23;17(11):e0278057. doi: 10.1371/journal.pone.0278057. eCollection 2022.
5
Post-Intensive Care Syndrome Prevalence Six Months after Critical Covid-19: Comparison between First and Second Waves.新冠肺炎重症监护后综合征发病六个月：第一波和第二波比较。
J Rehabil Med. 2022 Oct 28;54:jrm00339. doi: 10.2340/jrm.v54.4363.
6
Ecosystem restoration is integral to humanity's recovery from COVID-19.生态系统恢复对于人类从 COVID-19 中恢复至关重要。
Lancet Planet Health. 2022 Sep;6(9):e769-e773. doi: 10.1016/S2542-5196(22)00171-1.
7
Mechanisms of Post-critical Illness Cardiovascular Disease.危重症后心血管疾病的机制
Front Cardiovasc Med. 2022 Jul 15;9:854421. doi: 10.3389/fcvm.2022.854421. eCollection 2022.
8
Nutritional priorities in patients with severe COVID-19.重症 COVID-19 患者的营养重点。
Curr Opin Clin Nutr Metab Care. 2022 Jul 1;25(4):277-281. doi: 10.1097/MCO.0000000000000835.
9
Post-Intensive Care Syndrome in Survivors from Critical Illness including COVID-19 Patients: A Narrative Review.危重症幸存者的重症监护后综合征，包括新冠肺炎患者：一篇叙述性综述
Life (Basel). 2022 Jan 12;12(1):107. doi: 10.3390/life12010107.
10
ICU-Acquired Pneumonia Is Associated with Poor Health Post-COVID-19 Syndrome.重症监护病房获得性肺炎与新冠后综合征患者的健康状况不佳有关。
J Clin Med. 2021 Dec 31;11(1):224. doi: 10.3390/jcm11010224.
本文引用的文献
1
Niacin Cures Systemic NAD Deficiency and Improves Muscle Performance in Adult-Onset Mitochondrial Myopathy.烟酰胺可治疗系统性 NAD 缺乏症，并改善成年起病的线粒体肌病患者的肌肉性能。
Cell Metab. 2020 Jun 2;31(6):1078-1090.e5. doi: 10.1016/j.cmet.2020.04.008. Epub 2020 May 7.
2
β2 adrenergic receptor-mediated signaling regulates the immunosuppressive potential of myeloid-derived suppressor cells.β2 肾上腺素能受体介导的信号转导调节髓源性抑制细胞的免疫抑制潜力。
J Clin Invest. 2019 Dec 2;129(12):5537-5552. doi: 10.1172/JCI129502.
3
Long-term Host Immune Response Trajectories Among Hospitalized Patients With Sepsis.住院脓毒症患者的长期宿主免疫反应轨迹。
JAMA Netw Open. 2019 Aug 2;2(8):e198686. doi: 10.1001/jamanetworkopen.2019.8686.
4
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial.非心脏手术后心肌损伤患者的达比加群治疗（MANAGE）：一项国际性、随机、安慰剂对照试验。
Lancet. 2018 Jun 9;391(10137):2325-2334. doi: 10.1016/S0140-6736(18)30832-8.
5
Impact of angiotensin-converting enzyme inhibitors or receptor blockers on post-ICU discharge outcome in patients with acute kidney injury.血管紧张素转换酶抑制剂或受体阻滞剂对急性肾损伤患者 ICU 出院后结局的影响。
Intensive Care Med. 2018 May;44(5):598-605. doi: 10.1007/s00134-018-5160-6. Epub 2018 May 15.
6
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
7
Systemic inflammation after critical illness: relationship with physical recovery and exploration of potential mechanisms.危重病后全身炎症：与身体恢复的关系及潜在机制的探讨。
Thorax. 2016 Sep;71(9):820-9. doi: 10.1136/thoraxjnl-2015-208114. Epub 2016 Apr 26.
8
Broad defects in the energy metabolism of leukocytes underlie immunoparalysis in sepsis.严重脓毒症患者白细胞能量代谢存在广泛缺陷，导致免疫麻痹。
Nat Immunol. 2016 Apr;17(4):406-13. doi: 10.1038/ni.3398. Epub 2016 Mar 7.
9
Retrospective Analysis of Long-Term Outcomes After Combat Injury: A Hidden Cost of War.战斗伤害长期后果的回顾性分析：战争的隐性代价。
Circulation. 2015 Dec 1;132(22):2126-33. doi: 10.1161/CIRCULATIONAHA.115.016950. Epub 2015 Nov 2.
10
Elucidation of novel 13-series resolvins that increase with atorvastatin and clear infections.阐明随阿托伐他汀增加并清除感染的新型13系列消退素。
Nat Med. 2015 Sep;21(9):1071-5. doi: 10.1038/nm.3911. Epub 2015 Aug 3.
Zotero 插件